Shahriar Saimon, Rana Md Sohel, Hossain Md Sabbir, Karim Ariful, Mredula Tasneem N, Nourin Nadia, Uddin Md Sahab, Amran Md Shah
Molecular Pharmacology and Herbal Drug Research Laboratory, Department of Pharmaceutical Chemistry, University of Dhaka, Dhaka 1000, Bangladesh.
Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka 1000, Bangladesh.
Curr Pharm Des. 2021;27(33):3502-3525. doi: 10.2174/1381612827666210224142446.
The pandemic, well-known as COVID-19, has been caused by the coronavirus SARS-CoV-2 and it has distinct characteristics from other coronavirus-related epidemics. This pandemic has been ravaging the whole world for more than a year now, and no drugs or vaccines have been found to eliminate this virus from the infected people effectively; only physical measures like social distancing, hand washing and face-mask wearing have been taken to reduce its spread and very recently Veklury (remdesivir) has been permitted by the USFDA to manage the critical patients. This disease can be asymptomatic, but when it is symptomatic, it presents with respiratory problems and cold- or flu-like symptoms, which can be diagnosed with a chest CT and confirmed with RT-PCR tests. In this review, the taxonomy and structure of SARS-CoV-2 and history, transmission, epidemiology, pathology, clinical features and impacts of the COVID-19 have been discussed. A summary of possible drug targets, attempted physical and chemical measures, as well as vaccine candidates, has also been provided. How this coronavirus is different from other coronaviruses, the obstacles in managing this disease and the possibility of a second wave have also been reviewed. This review represents a wide range of information regarding COVID-19 and intends to be used as a comprehensive overview in this regard.
这场大流行,也就是众所周知的COVID-19,是由冠状病毒SARS-CoV-2引起的,它具有与其他冠状病毒相关疫情不同的特征。这场大流行已经肆虐全球一年多了,目前尚未发现能有效清除感染者体内这种病毒的药物或疫苗;人们只采取了社交距离、洗手和戴口罩等物理措施来减少其传播,最近美国食品药品监督管理局(USFDA)已批准瑞德西韦(Veklury)用于治疗重症患者。这种疾病可能无症状,但出现症状时,会表现出呼吸道问题以及类似感冒或流感的症状,可通过胸部CT进行诊断,并通过逆转录聚合酶链反应(RT-PCR)检测加以确诊。在这篇综述中,讨论了SARS-CoV-2的分类学、结构以及COVID-19的历史、传播、流行病学、病理学、临床特征和影响。还提供了可能的药物靶点、尝试过的物理和化学措施以及候选疫苗的总结。此外,还回顾了这种冠状病毒与其他冠状病毒的不同之处、应对这种疾病的障碍以及二次疫情爆发的可能性。这篇综述涵盖了有关COVID-19的广泛信息,旨在作为这方面的全面概述。